Adolor Corporation Partner Glaxo Group Ltd. Plans Added Phase III Study on Its Bowel Drug

March 13, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

March 12 (Reuters) - Adolor Corp. (ADLR.O: Quote, Profile , Research) said on Monday that its partner Glaxo Group Ltd. has planned an additional Phase III study to evaluate the efficacy and safety of the experimental bowel treatment drug, Entereg.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase 3